Geron, Investors Reach $6.25M Settlement In Cancer Drug Suit
A proposed class of Geron Corp. investors have sought approval in California federal court for a $6.25 million settlement regarding claims that the company improperly touted a cancer drug before the...To view the full article, register now.
Already a subscriber? Click here to view full article